School of Public Health University of Haifa, Israel.
Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
J Anxiety Disord. 2022 Dec;92:102632. doi: 10.1016/j.janxdis.2022.102632. Epub 2022 Sep 16.
Despite increasing use of Medical Cannabis (MC) among posttraumatic stress disorder (PTSD) patients, research is lacking on how MC treatment relates to PTSD symptomatology, in particular sleep disturbances. This study examines the time gap between MC use and sleep onset and its association with (1) number of awakenings throughout the night, (2) early awakenings, (3) nightmares. Each morning over a two week period, 77 licensed MC patients suffering from PTSD reported on the timing of previous night MC use and sleep disturbances. Within-person analyses found that shorter time gaps between previous night MC use and sleep start time was associated with lower likelihood of experiencing nightmares throughout the night, but it was not associated with nightly awakenings or waking up too early. Between-person analyses showed that individuals who used MC products with higher CBD concentrations reported fewer early awakenings. These preliminary results indicate that future research should test causal relations between MC use and sleep problems in PTSD patients. Future research is warranted in order to explore causal relationships between MC use, nightmares and insomnia in PTSD patients.
尽管创伤后应激障碍(PTSD)患者越来越多地使用医用大麻(MC),但关于 MC 治疗与 PTSD 症状,特别是睡眠障碍之间关系的研究却很少。本研究考察了 MC 使用与入睡之间的时间间隔及其与(1)夜间觉醒次数、(2)早醒和(3)梦魇之间的关系。在两周的时间内,每天早上,77 名患有 PTSD 的持牌 MC 患者报告了前一晚 MC 使用和睡眠障碍的时间。个体内分析发现,前一晚 MC 使用与开始入睡之间的时间间隔越短,整个晚上出现梦魇的可能性越低,但与夜间觉醒或过早醒来无关。个体间分析表明,使用 CBD 浓度较高的 MC 产品的个体报告的早醒次数较少。这些初步结果表明,未来的研究应该在 PTSD 患者中测试 MC 使用与睡眠问题之间的因果关系。有必要进行未来的研究,以探索 PTSD 患者中 MC 使用、噩梦和失眠之间的因果关系。